Melanoma Coverage from Every Angle

Ana Maria Arance Fernandez, MD, PhD, on Melanoma Treatment in Light of the IMspire170 Trial

Posted: Monday, September 30, 2019

Ana Maria Arance Fernandez, MD, PhD, of the Hospital ClĂ­nic de Barcelona, discusses what the negative results of the IMspire170 trial indicate for the future role of combination therapies, such as cobimetinib and atezolizumab, in the treatment of advanced melanoma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.